Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk

Tundra lists 1 Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07682272

A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinoma

This study is conducted to evaluate the efficacy and safety of SHR-8068 combined with Adebrelimab and Apatinib compared with Adebrelimab combined with Apatinib in perioperative treatment of resectable hepatocellular carcinoma with intermediate or high recurrence risk.

Gender: All

Ages: 18 Years - 70 Years

Updated: 2026-07-02

1 state

Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk